MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Renal cell carcinoma treatment
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,551 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,551 works in the cohort · of 4,299,418page 16 of 52

Labels cover 11 of 2,551 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,551 of 2,551 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Renal radiofrequency ablation: Technique and results
J. Kyle Anderson, Edward D. Matsumoto, Jeffrey A. Cadeddu
2005· article· en· Urologic Oncology Seminars and Original Investigations· Medicine
machine prediction:candidate · noneconsensus · none
21
citations
affno abstractunlabeled
Surveillance of Small Renal Masses
Ardalan E. Ahmad, Antonio Finelli, Michael A.S. Jewett
2016· review· en· Urology· Medicine
machine prediction:candidate · noneconsensus · none
20
citations
affno abstractunlabeled
Magnetic resonance imaging (MRI) of the renal sinus
Satheesh Krishna, Nicola Schieda, Trevor A. Flood, Krishna Shanbhogue, Subramaniyan Ramanathan, Evan S. Siegelman
2018· review· en· Abdominal Radiology· Medicine
machine prediction:candidate · noneconsensus · none
20
citations
affgemma · no categorygpt · no categorymodels split
Outcomes in patients (pts) with advanced renal cell carcinoma (aRCC) who discontinued (DC) first-line nivolumab + ipilimumab (N+I) or sunitinib (S) due to treatment-related adverse events (TRAEs) in CheckMate 214.
Nizar M. Tannir, Robert J. Motzer, Elizabeth R. Plimack, David F. McDermott, Philippe Barthélémy, Camillo Porta +13 more
2019· article· en· Journal of Clinical Oncology· Medicine
machine prediction:candidate · noneconsensus · none
19
citations
affaboutno abstractunlabeled
Vancouver-Klassifikation von Nierentumoren
Glen Kristiansen, Brett Delahunt, John R. Srigley, Cora Lüders, Jens Lunkenheimer, Heidrun Gevensleben +3 more
2014· article· de· Der Pathologe· Medicine
machine prediction:candidate · noneconsensus · none
19
citations

How this was built: Screen · Findings · About